Apollo Therapeutics is to work closely with University of Oxford to help its academic scientists bring more novel potential first-in-class therapeutics to patients.
Apollo Bolsters Its R&D Strategy With Oxford University Alliance
Adding Oxford to its roster will help Apollo widen its net for potential first-in-class therapies, and connects with the university’s ambition to build world-beating spin-outs.
